Peptide record

TPDB21220

Antibacterial Anticancer Antiviral Toxicity modified_plain modified
37 source-reported length (unverified)
Basic Information
TPDB21220
Antibacterial Anticancer Antiviral Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia dbAMP 3.0
modified_plain
Yes
A modified multi-activity (Antibacterial, Anticancer, Antiviral, and other sources) peptide record curated from Peptipedia and dbAMP 3.0, without an available 3D structural model. Source-reported length: 37 (unverified).
Modified, details unspecified
Sequence
IEEIYKKIEEIYKKIEEIYKKIEEIYKKIEEIYKKXK

Source notation is retained verbatim; residue notation and chemical identity have not been independently validated. The displayed length is source-reported and unverified.

Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
37 source-reported length (unverified)
Evidence Records 2 records
Evidence 1 Activity

Activity

50% Cytotoxicity
Toxicity
>100 µM
Cytotoxic
50% Cytotoxicity | >100 | µM | target cell: Madin-Darby canine kidney cells

Target

Madin-Darby canine kidney cells

Source & Reference

NA
DBAASP
De Novo Design of alpha-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery. | J Med Chem | 2018
Evidence 2 Activity

Activity

Toxicity
Hemolytic Cytotoxic
Hemolytic_activity: Not available | Cytotoxicity: Not available

Target

erythrocytes

Source & Reference

NA
DRAMP
J Med Chem. 2018 Oct 11 61(19):8734-8745.